The cognitive diagnostics market is projected to grow at a CAGR of 7.21% over the forecast period, increasing from US$137.738 billion in 2025 to US$195.061 billion by 2030.
The cognitive diagnostics market pertains to medical technology focused on assessing and diagnosing cognitive disorders. This market is driven by several factors, including the increasing elderly population, the prevalence of chronic diseases, and heightened awareness of cognitive decline. Research indicates that cognitive functions such as memory, executive functions, processing speed, and reasoning may begin to deteriorate as early as a person's thirties. Additionally, studies show that mild cognitive impairment affects 10-20% of adults over 65, which can progress to more severe cognitive issues. Innovative products and new metrics related to cognitive functions are further propelling market growth. For instance, Muse by Interaxon launched a new cognitive performance metric called Alpha Peak in September 2024. This metric is part of a suite of advanced brain health tools that provide users with personalized insights to enhance cognitive performance through an easy-to-understand scoring system. Users can track lifestyle factors like diet, exercise, and sleep, correlating these with their Alpha Peak score and receiving tailored prompts for habit optimization.
The cognitive diagnostics market is segmented into regions including North America, South America, Europe, the Middle East & Africa, and Asia Pacific. The Asia Pacific region is anticipated to experience significant growth due to its expanding healthcare industry, increasing elderly population, and rising concerns about chronic diseases. According to the Asian Development Bank, by 2050, one in four individuals in Asia and the Pacific will be over 60 years old, with the population aged over 60 expected to triple from 2010 levels to nearly 1.3 billion. Rapid transitions are anticipated in countries such as China, Japan, South Korea, and Vietnam. Additionally, growing research into conditions like depression, insomnia, and PTSD will further drive demand for diagnostic tools aimed at improving quality of life for affected individuals in this region.
The cognitive diagnostics market pertains to medical technology focused on assessing and diagnosing cognitive disorders. This market is driven by several factors, including the increasing elderly population, the prevalence of chronic diseases, and heightened awareness of cognitive decline. Research indicates that cognitive functions such as memory, executive functions, processing speed, and reasoning may begin to deteriorate as early as a person's thirties. Additionally, studies show that mild cognitive impairment affects 10-20% of adults over 65, which can progress to more severe cognitive issues. Innovative products and new metrics related to cognitive functions are further propelling market growth. For instance, Muse by Interaxon launched a new cognitive performance metric called Alpha Peak in September 2024. This metric is part of a suite of advanced brain health tools that provide users with personalized insights to enhance cognitive performance through an easy-to-understand scoring system. Users can track lifestyle factors like diet, exercise, and sleep, correlating these with their Alpha Peak score and receiving tailored prompts for habit optimization.
Key Developments
- Strategic Partnerships: In August 2024, Firefly Neuroscience, Inc. announced a strategic partnership with Neurology Consultants of Dallas (NCD) to enhance early detection and disease management for patients experiencing cognitive decline. NCD will integrate Firefly’s Brain Network Analytics technology into its workflow and conduct clinical studies.
- Investment in Innovative Testing: In March 2024, C?N Diagnostics, LLC received an investment of up to $15 million from Eisai Inc. This collaboration aims to scale access to their Precivity tests - innovative blood tests designed for patients with cognitive impairment that assist healthcare providers in diagnosing Alzheimer’s disease pathology and informing treatment decisions.
Market Drivers
- Growing Geriatric Population: The increasing elderly population globally is a primary driver for the demand for cognitive diagnostics and treatments. The World Health Organization (WHO) projects that by 2030, one in six individuals will be aged 60 or older, totaling approximately 1.4 billion people. By 2050, this number is expected to reach 2.1 billion. The prevalence of diseases like Alzheimer's - the most common form of dementia - necessitates proper diagnostics and treatments, thereby fueling the cognitive diagnostics market.
Geographical Trends
The cognitive diagnostics market is segmented into regions including North America, South America, Europe, the Middle East & Africa, and Asia Pacific. The Asia Pacific region is anticipated to experience significant growth due to its expanding healthcare industry, increasing elderly population, and rising concerns about chronic diseases. According to the Asian Development Bank, by 2050, one in four individuals in Asia and the Pacific will be over 60 years old, with the population aged over 60 expected to triple from 2010 levels to nearly 1.3 billion. Rapid transitions are anticipated in countries such as China, Japan, South Korea, and Vietnam. Additionally, growing research into conditions like depression, insomnia, and PTSD will further drive demand for diagnostic tools aimed at improving quality of life for affected individuals in this region.
Reasons for buying this report:
- Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub-segments.
- Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
- Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
- Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
- Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence.Report Coverage:
- Historical data & forecasts from 2022 to 2030
- Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
- Competitive Positioning, Strategies, and Market Share Analysis
- Revenue Growth and Forecast Assessment of segments and regions including countries
- Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
Cognitive diagnostics market has been segmented as following:
- By Diagnosis
- Brain Imaging Tests
- Laboratory Testing
- Mental Status Testing
- Rapid Home Screening Tests
- Neuropsychological Testing
- Electroencephalogram (EEG)
- Cognitive Function and Behavioral Tests
- Neuropsychiatric Inventory Questionnaire
- By Indication
- Alzheimer’s Disease
- Attention Deficit / Hyperactivity Disorder
- Dementia
- Epilepsy-Related Cognitive Dysfunction
- Mild Cognitive Impairment
- Parkinson’s Disease-Related Cognitive Dysfunction
- Stroke-Related Cognitive Dysfunction
- Traumatic Brain Injury
- Others
- By End User
- Hospitals
- Neurology Clinics
- Cognitive Behavioral Therapy Centers
- Rehabilitation Centers
- Academic And Research Institutes
- Diagnostic Imaging Centers
- Others
- By Geography
- North America
- USA
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Others
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Others
- Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Others
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others
- North America
Table of Contents
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
5. COGNITIVE DIAGNOSTICS MARKET BY DIAGNOSIS
6. COGNITIVE DIAGNOSTICS MARKET BY INDICATION
7. COGNITIVE DIAGNOSTICS MARKET BY END USER
8. COGNITIVE DIAGNOSTICS MARKET BY GEOGRAPHY
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
10. COMPANY PROFILES
Companies Mentioned
- Cognivue, Inc.
- Cambridge Cognition Ltd.
- Diadem srl
- C2N Diagnostics
- Cogstate Ltd.
- Viz.ai
- Mind Maze
- Neurocare Group AG
- Anderson Diagnostics & Labs.
- Altoida AG
- BrainScope Company Inc.
- Neurotrack Technologies Inc.
- BrainCheck
- Cyclops MedTech Pvt Ltd
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | January 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 137.74 Billion |
| Forecasted Market Value ( USD | $ 195.06 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
